There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
"Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen."
"Babakhani; F,; et al,:clin, Infct, Dis,; 55; S162 (2012); Venugopal; A,; et al,:clin, Infct, Dis,; 54; 568 (2012)"
Purity by HPLC
Not less than 95%
Hazard Compound
Refer MSDS for accurate information.
Overview
"Fidaxomicin is a nonabsorbed macrocyclic antibiotic, and is the first antimicrobial to be approved by the FDA for the treatment of Clostridium difficile infection (CDI) in 20 years. Fidaxomicin works by inhibiting sporulation by CDI, sustaining clinical response and reducing recurrences of this pathogen."
"Babakhani; F,; et al,:clin, Infct, Dis,; 55; S162 (2012); Venugopal; A,; et al,:clin, Infct, Dis,; 54; 568 (2012)"
